Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
about
Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasisPHD2: from hypoxia regulation to disease progressionmiR-182 aids in receptive endometrium development in dairy goats by down-regulating PTN expressionSmall molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury.Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.MicroRNA-182 prevents vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ signaling.Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors.Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation?Hypoxia-responsive miR-124 and miR-144 reduce hypoxia-induced autophagy and enhance radiosensitivity of prostate cancer cells via suppressing PIM1.Understanding the CREB1-miRNA feedback loop in human malignancies.Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanism.The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts.Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over.MicroRNA-433 Inhibits the Proliferation and Migration of HUVECs and Neurons by Targeting Hypoxia-Inducible Factor 1 Alpha.Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cells
P2860
Q26747871-6F58DD34-022C-429F-A45C-0397DE72F734Q28069316-A3BD0B39-2D53-480A-B557-920695E78354Q33873856-7E274D21-DF37-4932-AEA4-0DDF2D05F1A7Q35968088-D01D3FC2-4CC8-4552-A122-77169A8A76A7Q36641178-B4B3A841-58D7-437C-AE2D-4DEA9903F2F0Q37062650-1138C434-B887-41C9-A9AA-85A1D2604094Q37215547-8E6A4EB4-9271-452E-BDF1-D07F69210F5FQ37706535-0B4A825F-DC5D-4361-B4C9-D7D36FB69D04Q37714151-54645B2A-63A3-44A1-960B-1E8FE51377BEQ38637217-CACBE8C6-B434-43FE-9EFF-3FE241ABDEDBQ38685090-672DC1C7-74A8-4DDE-A8BD-1881CC3DB509Q38785225-6EF1918F-258C-4843-B46A-933F1E100550Q38802458-E4D9AC5C-61AC-4F93-B35B-6C5F29E6AAA7Q40655691-1115A40F-C0EC-432B-94E2-29312F526C1CQ41331870-BC206DBB-DA83-4D84-9705-0DE7CB927941Q41718154-5EF1BFDF-4EA7-4BD7-8C36-50288405A3AEQ47368576-B0426F68-E984-4986-A252-D9BC4C63B06BQ54946576-E244BDD0-6B7B-457A-B33B-4B0A7EB02190Q58773797-BA9BADEB-5C77-49E8-AE69-83FF27CA91B9
P2860
Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@ast
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@en
type
label
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@ast
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@en
prefLabel
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@ast
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Hypoxia-inducible miR-182 enha ...... 2 and FIH1 in prostate cancer.
@en
P2093
Cunjie Chang
Hongfeng Xia
Shengjie Zhang
Xiaoyun Wang
P2860
P2888
P356
10.1038/SREP12495
P407
P577
2015-07-24T00:00:00Z